The results suggest that CBD could offer a treatment for the memory problems associated with psychosis, a common mental-health condition that affects 20 million people worldwide, according to the World Health Organization.
“Now not only do we know that CBD works as an antipsychotic, we know it targets the areas of the brain that need to be targeted. This really gives us confidence, and it gives us scientific justification for large scale clinical trials,” lead researcher on the study Sagnik Bhattacharyya tells Inverse.
Scientists compared brain scan results of people with a diagnosis of psychosis and people without the disorder as they were doing a memory exercise. In the people with psychosis, the researchers found clear differences in the activity patterns in their prefrontal, mediotemporal, and striatal areas of the brain — those that regulate decision making, learning and memory. But when these participants were given a single dose of CBD, their brain activity patterns were more similar to those of people without the disorder.
To read the rest of the story, click on https://www.inverse.com/mind-body/single-dose-cbd-treat-psychosis-study